Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mesa Laboratories (MLAB) Equity Average (2016 - 2025)

Mesa Laboratories' Equity Average history spans 15 years, with the latest figure at $182.6 million for Q4 2025.

  • On a quarterly basis, Equity Average rose 15.31% to $182.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $182.6 million, a 15.31% increase, with the full-year FY2025 number at $152.6 million, down 43.36% from a year prior.
  • Equity Average hit $182.6 million in Q4 2025 for Mesa Laboratories, up from $175.5 million in the prior quarter.
  • Over the last five years, Equity Average for MLAB hit a ceiling of $409.5 million in Q1 2021 and a floor of $148.1 million in Q2 2024.
  • Historically, Equity Average has averaged $306.6 million across 5 years, with a median of $383.9 million in 2022.
  • Biggest five-year swings in Equity Average: soared 79.9% in 2021 and later crashed 62.09% in 2024.
  • Tracing MLAB's Equity Average over 5 years: stood at $397.9 million in 2021, then dropped by 4.31% to $380.7 million in 2022, then increased by 3.85% to $395.4 million in 2023, then crashed by 59.95% to $158.3 million in 2024, then grew by 15.31% to $182.6 million in 2025.
  • Business Quant data shows Equity Average for MLAB at $182.6 million in Q4 2025, $175.5 million in Q3 2025, and $166.2 million in Q2 2025.